Concepedia

Ricardo Ramírez

RR

Statistics

Publications

17

Citations

1K

H-Index

15

Active since

2008

Affiliations

Gilead Sciences (United States)(Current)

Erasmus MC

Erasmus University Rotterdam

Hôpital Beaujon

Chinese University of Hong Kong

Ricardo Ramírez is an author at Gilead Sciences (United States) specializing in viral hepatitis, life sciences, and pharmacology.

ORCID

Publications per year

2008–2024

17

Publications

17

Acetyl‐CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents

Leigh Goedeke, Jamie Bates, Daniel F. Vatner et al. · Hepatology · 2018 · 251 citations

, , +17

Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation

Jamie Bates, Archana Vijayakumar, Sarani Ghoshal et al. · Journal of Hepatology · 2020 · 225 citations · Full text

, , +17

Multi-parametric analysis of human livers reveals variation in intrahepatic inflammation across phases of chronic hepatitis B infection

Noe Rico Montanari, Ricardo Ramírez, Abhishek Aggarwal et al. · Journal of Hepatology · 2022 · 80 citations · Full text

, , +14

Toll‐Like Receptor 8 Agonist GS‐9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B

Stéphane Daffis, Scott Balsitis, Jason Chamberlain et al. · Hepatology · 2020 · 72 citations · Full text

, , +15

Identification of NK Cell Subpopulations That Differentiate HIV-Infected Subject Cohorts with Diverse Levels of Virus Control

Christopher W. Pohlmeyer, Veronica D. Gonzalez, Alivelu Irrinki et al. · Journal of Virology · 2019 · 56 citations · Full text

, , +16

1–5 of 17